VERPACKTES MEDIKAMENT

European patent · EP3622941 · In force

Register entry

Publication number
EP3622941
Application number
EP18798510
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 1, 2018
Published
Mar 18, 2020
Granted
Nov 15, 2023
Protection ends at the latest
Apr 30, 2038
Next annual fee due
May 31, 2027
IPC classes
A61J 3/07 (2006.01)
A61J 3/00 (2006.01)
A61B 5/07 (2006.01)
H01Q 1/27 (2006.01)
Priority
WO PCT/JP2017/017537 09.05.2017
PCT application
PCT/JP2018/017426 01.05.2018
PCT publication
WO2018/207681 15.11.2018
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Sep 25, 2024

    Change

    Published in Swissreg on 25.09.2024

  4. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  5. Feb 12, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 12.02.2024

  6. Nov 15, 2023

    Granted

    Published in Swissreg on 15.11.2023

Parties

Holder

Otsuka Pharmaceutical Co., Ltd.

2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535, JP

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

KASHIHARA, Kenzo

Osaka-shi Osaka 540-0021, JP

YAMAMOTO, Kenta

Osaka-shi Osaka 540-0021, JP

YOKOI, Kazuma

Osaka-shi Osaka 540-0021, JP

SONOKI, Takahiro

Osaka-shi Osaka 540-0021, JP

YAMADA, Shohei

Osaka-shi Osaka 540-0021, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.